Zitat:"Second Quarter Fiscal 2017 Revenue Review
Revenue for the second quarter ended September 30, 2016 was $8.5 million compared to revenue of $2.5 million in the three months ended September 30, 2015 and $7.0 million for the first quarter of fiscal year 2017. Revenue in the six months ended September 30, 2016 totaled $15.5 million as compared to $4.2 million in the same period last year.
The Corporation had over 24,400 registered patients at September 30, 2016 compared to over 16,600 at June 30, 2016 and over 6,200 at September 30, 2015....
Second Quarter Fiscal 2017 Product Sales Review...
The total grams sold during the quarter ended September 30, 2016 was 1,169 kilograms and kilogram equivalents at an average price of $7.01 per gram, up from 984 kilograms and kilogram equivalents at an average price of $7.09 per gram in the first quarter of Fiscal 2017 and up from 319 kilograms sold during the three‑month period ended September 30, 2015 at an average price of $7.54 per gram. Year‑to‑date, the Company has sold 2,153 kilograms and kilogram equivalents at an average price of $7.05 per gram compared to 535 kilograms at an average price of $7.62 per gram in the six months ended September 30, 2015. " ENDE Zitat
Source:
http://www.stockwatch.com/News/...2421098&symbol=CGC®ion=C